Semaglutide is a glucagon-like peptide-1 receptor agonist administered as a subcutaneous injection once weekly
For anyone in hospitality tempted to view GLP 1 drugs as someone elses concern, the numbers already suggest otherwise
Similarly, regional initiatives like the European Green Deal and Sustainable Energy Action Plans (SEAPs) aim to decarbonize urban areas through integrated approaches, including Zero Energy Buildings (ZEBs), Net-Zero Energy Districts (NZEDs), and Positive Energy Districts (PEDs) (Sassenou et al., 2024)
Can Glucagon-like peptide-1 (GLP-1) receptor agonists, such as liraglutide (Victoza) or semaglutide (Ozempic), cause ongoing diarrhea after discontinuation?
2 Materials and methods To conduct this comprehensive literature review, a systematic approach encompassing several key steps was employed